Cost-Effectiveness of a Telemedicine Optometric-Based Assessment for Screening Diabetic Retinopathy in a Country with a Universal Public Health System

被引:0
|
作者
Ortiz-Toquero, Sara [1 ,2 ]
Aleixandre, Guillermo [3 ]
Valpuesta, Yolanda [4 ]
Fernandez, Cristina Perez [5 ]
de la Iglesia, Purificacion [6 ]
Pastor, Jose Carlos [1 ,5 ,7 ]
Lopez-Galvez, Maribel [1 ,5 ]
机构
[1] Univ Valladolid, IOBA Eye Inst, Paseo Bele,17 Campus Miguel Delibes, Valladolid 47011, Spain
[2] Univ Valladolid, Dept Theoret Phys Atom & Opt, Valladolid, Spain
[3] Univ Valladolid, Dept Appl Econ, Valladolid, Spain
[4] Salud Castilla y Leon, Medina de Rioseco Healthcare Ctr, Medina De Rioseco, Spain
[5] Univ Clin Hosp Valladolid, Dept Ophthalmol, Valladolid, Spain
[6] Reg Minist Hlth, Direcc Gen Asistencia Sanitaria, Consejeria Sanidad, Valladolid, Spain
[7] Inst Hlth Inflammat & immunopathol organs & Syst, RICORS Themat Network Carlos III, Madrid, Spain
关键词
diabetic retinopathy; screening program; telemedicine; optometrist; cost-effectiveness; retinal images; European country; UTILITY ANALYSIS; PROGRAM;
D O I
10.1089/tmj.2024.0353
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To determine the cost-effectiveness of a new telemedicine optometric-based screening program of diabetic retinopathy (DR) compared with traditional models' assessments in a universal European public health system.Methods: A new teleophthalmology program for DR based on the assessment of retinographies (3-field Joslin Vision Network by a certified optometrist and a reading center [IOBA-RC]) was designed. This program was first conducted in a rural area 40 km from the referral hospital (Medina de Rioseco, Valladolid, Spain). The cost-effectiveness was compared with telemedicine based on evaluations by primary care physicians and general ophthalmologists, and to face-to-face examinations conducted by ophthalmologists. A decision tree model was developed to simulate the cost-effectiveness of both models, considering public and private costs. The effectiveness was measured in terms of quality of life.Results: A total of 261 patients with type 2 diabetes were included (42 had significant DR and required specific surveillance by the RC; 219 were undiagnosed). The sensitivity and specificity of the detection of DR were 100% and 74.1%, respectively. The telemedicine-based DR optometric screening model demonstrated similar utility to models based on physicians and general ophthalmologists and traditional face-to-face evaluations (0.845) at a lower cost/patient (<euro>51.23, <euro>71.65, and <euro>86.46, respectively).Conclusions: The telemedicine-based optometric screening program for DR in a RC demonstrated cost savings even in a developed country with a universal health care system. These results support the expansion of this kind of teleophthalmology program not only for screening but also for the follow-up of diabetic patients.
引用
收藏
页码:2824 / 2833
页数:10
相关论文
共 50 条
  • [21] Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi
    Vetrini, Damir
    Kiire, Christine A.
    Burgess, Philip I.
    Harding, Simon P.
    Kayange, Petros C.
    Kalua, Khumbo
    Msukwa, Gerald
    Beare, Nicholas A. V.
    Madan, Jason
    PLOS ONE, 2018, 13 (01):
  • [22] Implementing preconception expanded carrier screening in a universal health care system: A model-based cost-effectiveness analysis
    Busnelli, Andrea
    Ciani, Oriana
    Caroselli, Silvia
    Figliuzzi, Matteo
    Poli, Maurizio
    Levi-Setti, Paolo Emanuele
    Tarricone, Rosanna
    Capalbo, Antonio
    GENETICS IN MEDICINE, 2023, 25 (11)
  • [23] Cost-effectiveness Analysis of a Personalized, Teleretinal-Inclusive Screening Policy for Diabetic Retinopathy via Markov Modeling
    Dorali, Poria
    Shahmoradi, Zahed
    Weng, Christina Y.
    Lee, Taewoo
    OPHTHALMOLOGY RETINA, 2023, 7 (06): : 532 - 542
  • [24] Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes
    Wolf, Risa M.
    Channa, Roomasa
    Abramoff, Michael D.
    Lehmann, Harold P.
    JAMA OPHTHALMOLOGY, 2020, 138 (10) : 1063 - 1069
  • [25] Comparison of the cost-effectiveness of three approaches to screening for and treating sight-threatening diabetic retinopathy
    Porta, M
    Rizzitiello, A
    Tomalino, M
    Trento, M
    Passera, P
    Minonne, A
    Pomero, F
    Gamba, S
    Castellazzi, R
    Montanaro, M
    Sivieri, R
    Orsi, R
    Bondonio, P
    Molinatti, GM
    DIABETES & METABOLISM, 1999, 25 (01) : 44 - 53
  • [26] Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland
    Heininger, Ulrich
    Pillsbury, Matthew
    Samant, Salome
    Lienert, Florian
    Guggisberg, Patrik
    Gani, Ray
    O'Brien, Elliott
    Pawaskar, Manjiri
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (06) : E217 - E221
  • [27] Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT
    Broadbent, Deborah M.
    Wang, Amu
    Cheyne, Christopher P.
    James, Marilyn
    Lathe, James
    Stratton, Irene M.
    Roberts, John
    Moitt, Tracy
    Vora, Jiten P.
    Gabbay, Mark
    Garcia-Finana, Marta
    Harding, Simon P.
    DIABETOLOGIA, 2021, 64 (01) : 56 - 69
  • [28] Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT
    Deborah M. Broadbent
    Amu Wang
    Christopher P. Cheyne
    Marilyn James
    James Lathe
    Irene M. Stratton
    John Roberts
    Tracy Moitt
    Jiten P. Vora
    Mark Gabbay
    Marta García-Fiñana
    Simon P. Harding
    Diabetologia, 2021, 64 : 56 - 69
  • [29] Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists
    van katwyk, Sasha
    Jin, Ya-ping
    Trope, Graham E.
    Buys, Yvonne
    Masucci, Lisa
    Wedge, Richard
    Flanagan, John
    Brent, Michael H.
    El-Defrawy, Sherif
    Tu, Hong Anh
    Thavorn, Kednapa
    VALUE IN HEALTH, 2017, 20 (08) : 1034 - 1040
  • [30] An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany
    Largeron, Nathalie
    Petry, Karl Ulrich
    Jacob, Jorge
    Bianic, Florence
    Anger, Delphine
    Uhart, Mathieu
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (01) : 85 - 98